The move will bring enormous tax benefits to medical marijuana producers and may speed research into its effects, experts say.

Trump administration eases federal restrictions on medical marijuana, expanding research and tax relief without legalizing it nationwide.

The U.S. administration reclassified state-licensed or FDA approved marijuana products from a Schedule I to a Schedule III drug. This reclassification does not immediately change marijuana's legal ...

Acting Attorney General Todd Blanche signed an order Thursday reclassifying state-licensed medical marijuana as a less dangerous drug, changing a policy that has for decades made the drug’s potential ...

Nearly four decades ago, Francis Young, chief administrative law judge at the Drug Enforcement Administration (DEA), concluded that marijuana did not belong in Schedule I of the Controlled Substances ...

For more than 50 years, marijuana has been classified as a Schedule I drug, alongside drugs considered to have no accepted medical use, thanks to then-President Richard Nixon’s so-called War on Drugs.

The reclassification doesn't suddenly make pot legal in the U.S., but it does mark an important shift in the country's relationship with the drug.

JACKSONVILLE, Fla. — The status of marijuana is on the verge of changing after an executive order signed by President Trump on Thursday. Right now, marijuana remains on the federal Schedule One list ...

For years, marijuana has been classified as a Schedule I drug under the federal Controlled Substance Act. Heroin, LSD, peyote, and quaaludes are other drugs that fall under the Schedule I ...

On April 22, the U.S. Department of Justice (DOJ) issued a final administrative order placing certain marijuana products into Schedule III of the Controlled Substances Act (CSA). The action, which is ...

Sen. Tom Cotton (R-Ark.) on Thursday criticized the Department of Justice’s (DOJ) decision to downgrade state-approved medical marijuana to a less dangerous drug. “Marijuana today is much more potent ...